Blood test trial aims to outsmart breast cancer relapse
NCT ID NCT06680596
Summary
This study has two parts. First, it uses a blood test to find patients with a specific type of metastatic breast cancer who still have cancer DNA in their blood after one month of standard therapy. In the second part, those patients switch to a different drug, trastuzumab deruxtecan, to see if it can better control the cancer and delay its progression. The main goal is to see if this guided approach helps patients live longer without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE IV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Eugene Marquis
Rennes, France
-
Centre Hospitalier Alpes Léman
Contamine-sur-Arve, 74130, France
-
Centre Hospitalier D'Auxerre
Auxerre, 89000, France
-
Centre Hospitalier William Morey
Chalon-sur-Saône, 71100, France
-
Centre Hospitalier de Beauvais
Beauvais, 60021, France
-
Centre Hospitalier de Cholet
Cholet, 49300, France
-
Centre Hospitalier de Pau
Pau, 64046, France
-
Centre Hospitalier de la Côte Basque
Bayonne, 64100, France
-
Centre Jean Perrin
Clermont-Ferrand, 63011, France
-
Centre Léon Bérard
Lyon, 69008, France
-
Chd Vendée
La Roche-sur-Yon, 85925, France
-
Chi Fréjus-Saint-Raphaël
Fréjus, 83608, France
-
Chp Saint-Grégoire - Groupe Vivalto Sante
Saint-Grégoire, 35760, France
-
Chu Amiens Picardie
Amiens, 80054, France
-
Chu de Brest - Hôpital Cavale Blanche
Brest, 29200, France
-
Clinique Pasteur Lanroze - Cfro - Groupe Vivalto Sante
Brest, 29200, France
-
Clinique Sainte-Anne - Gh Saint-Vincent
Strasbourg, 67000, France
-
Clinique de L'Europe Amiens - Cthe
Amiens, 80090, France
-
Clinique de La Sauvegarde
Lyon, 69009, France
-
Groupe Hospitalier Diaconesses Croix Saint-Simon
Paris, 75020, France
-
Gustave Roussy
Villejuif, France
-
Hopital Prive Jean Mermoz
Lyon, 69008, France
-
Hopital Privé Des Côtes D'Armor (Hpca) - Cario
Plérin, 22190, France
-
Hôpital Saint-Louis
Paris, 75010, France
-
Hôpital Simone Veil de Blois
Blois, 41000, France
-
Hôpitaux Du Léman
Thonon-les-Bains, 74200, France
-
Icm Val D'Aurelle
Montpellier, 34298, France
-
Institut Godinot
Reims, 51100, France
-
Institut Paoli Calmettes
Marseille, 13009, France
-
Institut de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, 054519, France
-
Medipôle de Nancy - Cog-Ilc (Polyclinique de Gentilly)
Nancy, 54100, France
-
Pôle Santé République (Elsan)
Clermont-Ferrand, 63000, France
-
Sainte Catherine Institut Du Cancer Avignon Provence
Avignon, 84918, France
Conditions
Explore the condition pages connected to this study.